Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 2Completed 2Active not recruiting 2Withdrawn 1Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 64INDUSTRY 17OTHER_GOV 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 13Leukemia, Myeloid, Acute 12Colorectal Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Rectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neoplasms 6Head and Neck Neoplasms 6Fallopian Tube Neoplasms 6Prostatic Neoplasms 5Pancreatic Neoplasms 5Multiple Myeloma 5Leukemia 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Vulvar Neoplasms 3Recurrence 3Lymphoma, Non-Hodgkin 3Lymphoma 3Liver Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Fatigue 3Depression 3Central Nervous System Neoplasms 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Stress Disorders, Post-Traumatic 2Small Cell Lung Carcinoma 2

Interventions

regorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × NETWORK × Carcinoma × Clear all
NCT02773524 2022-01-13

INTEGRATEIIa

Australasian Gastro-Intestinal Trials Group

Phase 3 Unknown
250 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡